Viewing Study NCT06894693

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:08 AM
Ignite Modification Date: 2025-12-25 @ 11:19 PM
Study NCT ID: NCT06894693
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-03-25
First Post: 2025-03-18
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies
Sponsor: Guangdong Ruishun Biotech Co., Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Non-Hodgkin's Lymphoma View
None Acute Lymphoblastic Leukemia View
Keywords: